We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$38.7M
2
IFF icon
International Flavors & Fragrances
IFF
+$27.4M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$14.7M
4
COP icon
ConocoPhillips
COP
+$14.5M
5
RPRX icon
Royalty Pharma
RPRX
+$9.46M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBFO
2851
DELISTED
United Security Bancshares
UBFO
$185K ﹤0.01%
22,534
– –
CBIO
2852
Crescent Biopharma
CBIO
$626M
$183K ﹤0.01%
607
– –
CMCL icon
2853
Caledonia Mining Corp
CMCL
$420M
$182K ﹤0.01%
12,706
-590
-4% -$9.08K
CRD.A icon
2854
Crawford & Co Class A
CRD.A
$669M
$182K ﹤0.01%
17,103
-790
-4% -$7.17K
HBT icon
2855
HBT Financial
HBT
$1.32B
$181K ﹤0.01%
10,560
-440
-4% -$7.14K
AGTC
2856
DELISTED
Applied Genetic Technologies Corporation
AGTC
$181K ﹤0.01%
35,627
+6,760
+23% +$35.1K
SRT
2857
DELISTED
Startek Inc.
SRT
$180K ﹤0.01%
22,606
+70
+0.3% +$580
DYN icon
2858
Dyne Therapeutics
DYN
$4.9B
$179K ﹤0.01%
+11,548
New +$223K
XFOR icon
2859
X4 Pharmaceuticals
XFOR
$460M
$178K ﹤0.01%
688
-25
-4% -$6.57K
KODK icon
2860
Kodak
KODK
$983M
$174K ﹤0.01%
22,165
-620
-3% -$5.65K
VATE icon
2861
INNOVATE Corp
VATE
$165M
$174K ﹤0.01%
4,420
-803
-15% -$29.8K
SAMG icon
2862
Silvercrest Asset Management
SAMG
$79.9M
$173K ﹤0.01%
12,032
-570
-5% -$8.38K
CASI
2863
DELISTED
CASI Pharmaceuticals
CASI
$172K ﹤0.01%
7,159
-170
-2% -$4.77K
TYME
2864
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$172K ﹤0.01%
96,856
+275
+0.3% +$571
WVE icon
2865
Wave Life Sciences
WVE
$1.2B
$171K ﹤0.01%
30,515
-365
-1% -$3.51K
ABEO icon
2866
Abeona Therapeutics
ABEO
$413M
$169K ﹤0.01%
3,595
– –
EXTN
2867
DELISTED
Exterran Corporation
EXTN
$169K ﹤0.01%
50,219
-44,072
-47% -$204K
CALA
2868
DELISTED
Calithera Biosciences, Inc
CALA
$169K ﹤0.01%
3,496
-192
-5% -$11.2K
GYRE icon
2869
Gyre Therapeutics
GYRE
$744M
$166K ﹤0.01%
4,398
+440
+11% +$20.1K
SBT
2870
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$166K ﹤0.01%
29,391
+100
+0.3% +$520
CORR
2871
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$164K ﹤0.01%
23,163
-2,498
-10% -$20K
CABA icon
2872
Cabaletta Bio
CABA
$455M
$163K ﹤0.01%
14,694
-760
-5% -$9.28K
ARQ icon
2873
Arq
ARQ
$89.3M
$162K ﹤0.01%
29,387
– –
PVLA
2874
Palvella Therapeutics
PVLA
$2.27B
$162K ﹤0.01%
786
+1
+0.1% +$219
EPM icon
2875
Evolution Petroleum
EPM
$131M
$161K ﹤0.01%
47,631
+100
+0.2% +$345
113 114
115
116 117

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.